Correlation Between Agios Pharm and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Agios Pharm and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Madrigal Pharmaceuticals.
Diversification Opportunities for Agios Pharm and Madrigal Pharmaceuticals
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Agios and Madrigal is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Agios Pharm i.e., Agios Pharm and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Agios Pharm and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Agios Pharm is expected to generate 1.91 times less return on investment than Madrigal Pharmaceuticals. But when comparing it to its historical volatility, Agios Pharm is 1.9 times less risky than Madrigal Pharmaceuticals. It trades about 0.31 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 21,593 in Madrigal Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 11,552 from holding Madrigal Pharmaceuticals or generate 53.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agios Pharm vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Agios Pharm |
| Madrigal Pharmaceuticals |
Agios Pharm and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agios Pharm and Madrigal Pharmaceuticals
The main advantage of trading using opposite Agios Pharm and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |